ערך בספרים למניה: elevaiskincare.com (ELAB)

Elevai Labs Inc. (ELAB) is demonstrating an expansion phase by releasing innovative skin regeneration products. The trend in book value per share confirms this growth, with the metric currently standing at 27.20. The business relies on robotic component purification to ensure serum purity and is creating a closed ecosystem that connects cosmetologists with the brand's exosome products.

Book value per share is calculated as the ratio of equity minus liabilities to the number of shares, reflecting the actual value of net assets per unit of ownership. Growth in this metric confirms the capitalization of intellectual property in biomedicine and the expansion of Elevai Labs Inc. (ELAB) within the regenerative cosmetics segment, as clearly demonstrated by the book value per share history on the GURU.Markets platform.